Anal fistula

3 trials 1 recruiting MedDRA PT
3 Registered trials
1 Recruiting
3 Unique sponsors
3 Unique IMPs
1 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
— ATC code not specified 1
J Anti-infectives (ATC J) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Fluoroquinolone 1 substance
Azole antifungal 1 substance
Phase II/III: 1 Phase IV: 2

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase II/III

1 trial
  • Uniwersytet Jagiellonski Collegium Medicum Academic
    IMP not specified
    2024-518898-34-00 1 country 2026 n=48
    Recruiting

Phase IV

2 trials
  • Takeda Development Center Americas Inc. Commercial
    ALLOGENEIC ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS EXPANDED
    2022-503014-23-00 5 countries 2020 n=45 Orphan
    Ended
  • Amsterdam UMC Stichting Academic
    CIPROFLOXACIN; METRONIDAZOLE
    2024-517233-40-00 1 country n=298
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Takeda Development Center Americas Inc. Commercial 1 Phase IV 0
Uniwersytet Jagiellonski Collegium Medicum Academic 1 Phase II/III 1
Amsterdam UMC Stichting Academic 1 Phase IV 0
New trials by year
2020
1
2026
1
← All indication landscapes